ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	23/141	120/7206	4.50645465343e-17
ko04621	NOD-like receptor signaling pathway	23/141	157/7206	2.10521045438e-14
ko04380	Osteoclast differentiation	20/141	134/7206	8.53058954711e-13
ko04064	NF-kappa B signaling pathway	17/141	96/7206	2.85947446424e-12
ko04217	Necroptosis	21/141	178/7206	2.32849559777e-11
ko04210	Apoptosis	21/141	180/7206	2.89051090873e-11
ko05161	Hepatitis B	20/141	173/7206	1.05843987156e-10
ko04620	Toll-like receptor signaling pathway	15/141	100/7206	6.8356544338e-10
ko05160	Hepatitis C	17/141	153/7206	5.50437921545e-09
ko04657	IL-17 signaling pathway	13/141	87/7206	1.04857262715e-08
ko05168	Herpes simplex infection	18/141	182/7206	1.23090932754e-08
ko05152	Tuberculosis	18/141	187/7206	1.89040206871e-08
ko05164	Influenza A	17/141	167/7206	2.09410684015e-08
ko04622	RIG-I-like receptor signaling pathway	11/141	62/7206	2.35749295221e-08
ko05167	Kaposi's sarcoma-associated herpesvirus infection	18/141	191/7206	2.6373151712e-08
ko04623	Cytosolic DNA-sensing pathway	9/141	41/7206	6.69985512675e-08
ko04060	Cytokine-cytokine receptor interaction	17/141	191/7206	1.53663334128e-07
ko05142	Chagas disease (American trypanosomiasis)	14/141	130/7206	1.98268064459e-07
ko05162	Measles	13/141	120/7206	5.17039106629e-07
ko04630	Jak-STAT signaling pathway	13/141	132/7206	1.5559312608e-06
ko05134	Legionellosis	9/141	74/7206	1.22218209347e-05
ko04624	Toll and Imd signaling pathway	7/141	49/7206	4.0893146385e-05
ko04933	AGE-RAGE signaling pathway in diabetic complications	11/141	135/7206	6.13663859085e-05
ko04115	p53 signaling pathway	8/141	74/7206	8.93474768028e-05
ko05140	Leishmaniasis	8/141	75/7206	9.83847771007e-05
ko05145	Toxoplasmosis	10/141	126/7206	0.000166590567659
ko05203	Viral carcinogenesis	15/141	277/7206	0.000316137039798
ko01524	Platinum drug resistance	7/141	76/7206	0.000670748884258
ko05169	Epstein-Barr virus infection	12/141	206/7206	0.000675875029318
ko04660	T cell receptor signaling pathway	9/141	124/7206	0.000686224910463
ko05321	Inflammatory bowel disease (IBD)	6/141	56/7206	0.000732755985238
ko04932	Non-alcoholic fatty liver disease (NAFLD)	11/141	182/7206	0.000837266133175
ko04659	Th17 cell differentiation	8/141	106/7206	0.00105762612938
ko05202	Transcriptional misregulation in cancer	11/141	188/7206	0.00109350570215
ko04722	Neurotrophin signaling pathway	10/141	160/7206	0.00111862387024
ko04931	Insulin resistance	9/141	137/7206	0.0013982931225
ko04917	Prolactin signaling pathway	7/141	87/7206	0.00150007174718
ko05133	Pertussis	7/141	87/7206	0.00150007174718
ko04662	B cell receptor signaling pathway	7/141	88/7206	0.00160354304348
ko04920	Adipocytokine signaling pathway	7/141	89/7206	0.00171249498072
ko05222	Small cell lung cancer	7/141	89/7206	0.00171249498072
ko04215	Apoptosis - multiple species	5/141	47/7206	0.00211691821227
ko04658	Th1 and Th2 cell differentiation	7/141	96/7206	0.00264541029556
ko04214	Apoptosis - fly	6/141	72/7206	0.00273133767371
ko04080	Neuroactive ligand-receptor interaction	1/141	423/7206	0.00323855915584
ko05200	Pathways in cancer	19/141	492/7206	0.00369293998619
ko05131	Shigellosis	6/141	82/7206	0.00522174830536
ko05120	Epithelial cell signaling in Helicobacter pylori infection	6/141	92/7206	0.00907545189935
ko05132	Salmonella infection	6/141	98/7206	0.0121853094709
ko05146	Amoebiasis	6/141	99/7206	0.012768370408
ko05219	Bladder cancer	4/141	48/7206	0.0140433279709
ko05014	Amyotrophic lateral sclerosis (ALS)	5/141	74/7206	0.0146198938106
ko04062	Chemokine signaling pathway	9/141	201/7206	0.0168201876913
ko05418	Fluid shear stress and atherosclerosis	8/141	173/7206	0.0199174322401
ko04930	Type II diabetes mellitus	4/141	54/7206	0.0208710145054
ko05215	Prostate cancer	6/141	111/7206	0.0213595541706
ko05206	MicroRNAs in cancer	8/141	177/7206	0.0225033908661
ko05212	Pancreatic cancer	5/141	83/7206	0.0229422116764
ko04940	Type I diabetes mellitus	3/141	32/7206	0.0240412100536
ko05143	African trypanosomiasis	3/141	32/7206	0.0240412100536
ko05323	Rheumatoid arthritis	5/141	89/7206	0.0299154431619
ko01522	Endocrine resistance	6/141	124/7206	0.0343624078067
ko05221	Acute myeloid leukemia	4/141	63/7206	0.0343971317144
ko04010	MAPK signaling pathway	12/141	321/7206	0.0347415058832
ko04650	Natural killer cell mediated cytotoxicity	5/141	97/7206	0.0411040470162
ko04915	Estrogen signaling pathway	6/141	131/7206	0.0431157754471
ko05332	Graft-versus-host disease	2/141	18/7206	0.0474022551905